Low dose temazepam
DC CAFC
First Claim
Patent Images
1. A method of treating insomnia in a human in need of said treatment which comprises administering orally to said human a temazepam formulation consisting essentially of 6 to 8 milligrams of crystalline temazepam having a surface area of from 0.65 to 1.1 m2 /g and 95% of the temazepam having a particle size of less than 65 microns.
4 Assignments
Litigations
0 Petitions
Accused Products
Abstract
This invention relates to a hard gelatin capsule containing no more than 5 to 10 milligrams of crystalline temazepam and its use in the treatment of transient insomnia.
22 Citations
2 Claims
-
1. A method of treating insomnia in a human in need of said treatment which comprises administering orally to said human a temazepam formulation consisting essentially of 6 to 8 milligrams of crystalline temazepam having a surface area of from 0.65 to 1.1 m2 /g and 95% of the temazepam having a particle size of less than 65 microns.
-
2. A method of treating insomnia in a human in need of said treatment which comprises administering orally to said human a temazepam formulation consisting essentially of 7.5 milligrams of crystalline temazepam having a surface area of from 0.65 to 1.1 m2 /g and 95% of the temazepam having a particle size of less than 65 microns.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
-
Current AssigneeMallinckrodt Incorporated (Mallinckrodt plc)
-
Original AssigneeNovartis Pharmaceuticals Corporation (Novartis Ag)
-
InventorsSterling, William R.
-
Primary Examiner(s)Rose, Shep K.
-
Application NumberUS08/424,135Time in Patent Office757 DaysField of Search514/221US Class Current514/221CPC Class CodesC07D 243/24 Oxygen atoms
